|
Market Closed -
NYSE
01:30:03 31/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 18.19 USD | -2.26% |
|
-1.89% | -23.67% |
| 22/10 | Arcus Biosciences Prices $250 Million Common Stock Offering; Shares Down Pre-Bell | MT |
| 21/10 | Wedbush Adjusts Price Target on Arcus Biosciences to $49 From $43, Keeps Outperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARCUS BIOSCIENCES, INC. | Other Biotechnology & Medical Research | -2.26% | -1.89% | -23.67% | -9.91% | -46.66% | 267.54Cr |  | | |
- Stock Market
- Stocks
- RCUS Stock
- Charts Arcus Biosciences, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
